Peripheral Arterial Disease
Concept
Vocabulary Service
Overview
subject area of
-
A MultiCenter Pilot Randomized Controlled Trial of Remote Ischemic Preconditioning in Major Vascular Surgery Academic Article
-
A National Canadian Survey of Antithrombotic Therapy After Urgent and Emergent Limb Revascularization Academic Article
-
Anticoagulation therapy in 2015: where we are and where we are going Academic Article
-
Antithrombotic Agents Academic Article
-
Antithrombotic Therapy for Peripheral Artery Disease Academic Article
-
Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making Academic Article
-
Antithrombotics in stable peripheral artery disease Academic Article
-
Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus Academic Article
-
Assessing Limb Outcomes in Drug Trials in Peripheral Artery Disease: The Need for a Universal and Pragmatic Definition Academic Article
-
Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review Academic Article
-
Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis Academic Article
-
Building Your Peripheral Artery Disease Toolkit: Medical Management of Peripheral Artery Disease in 2022 Academic Article
-
COMPASS for Vascular Surgeons Academic Article
-
Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease Academic Article
-
Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up Academic Article
-
Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease Academic Article
-
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk Academic Article
-
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1 Academic Article
-
Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial Academic Article
-
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease Academic Article
-
Consensus Document on Intermittent Claudication from the Central European Vascular Forum (C.E.V.F.)-3rd revision (2013) with the sharing of the Mediterranean League of Angiology and Vascular Surgery, and the North Africa and Middle East Chapter of International Union of Angiology. Academic Article
-
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial Academic Article
-
Diet and Nutrition in Peripheral Artery Disease: A Systematic Review Academic Article
-
Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort Academic Article
-
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence Academic Article
-
Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances Academic Article
-
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial Academic Article
-
Effects of basal insulin glargine and omega‐3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial Academic Article
-
Effects of the dual peroxisome proliferator–activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes Academic Article
-
Efficacy and safety of dapagliflozin were similar in patients with type 2 DM and atherosclerotic CVD, regardless of PAD Academic Article
-
Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease Academic Article
-
Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD Academic Article
-
Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease Academic Article
-
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry Academic Article
-
External applicability of the COMPASS trial: the Western Denmark Heart Registry Academic Article
-
Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease Academic Article
-
Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease Academic Article
-
How can the results of the COMPASS trial benefit patients with coronary or peripheral artery disease in Poland? Academic Article
-
Identifying and Treating Young Patients at Risk for Cardiovascular Events Academic Article
-
Impact of Arterial Procedures on Coagulation and Fibrinolysis – A Pilot Study Academic Article
-
Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD Academic Article
-
Inclusion of People With Peripheral Artery Disease in Cardiac Rehabilitation Programs: A Pan-Canadian Survey Academic Article
-
Inflammation as a Mechanism and Therapeutic Target in Peripheral Artery Disease Academic Article
-
Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy Academic Article
-
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48 Academic Article
-
Leukotrienes biosynthesis in vascular surgery patients during perioperative period. Academic Article
-
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial Academic Article
-
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials Academic Article
-
Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial Academic Article
-
Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease Academic Article
-
Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin Academic Article
-
Microvascular disease increases the risk of lower limb amputation – A Western Danish cohort study Academic Article
-
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease Academic Article
-
Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study Academic Article
-
New developments in anticoagulants: Past, present and future Academic Article
-
Outcome of aortoiliac, femoropopliteal and infrapopliteal endovascular interventions in lesions categorised by TASC classification Academic Article
-
Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia Academic Article
-
Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry Academic Article
-
Patients with Peripheral Artery Disease in the COMPASS Trial Academic Article
-
Perioperative cardiovascular complications rate and activity of coagulation and fibrinolysis among patients undergoing vascular surgery for peripheral artery disease and abdominal aortic aneurysm Academic Article
-
Peripheral Artery Disease: A High-Risk Yet Understudied, Underdiagnosed, and Undertreated Condition—A Call to Action Academic Article
-
Position Statement on Noninvasive Imaging of Peripheral Arterial Disease by the Society of Interventional Radiology and the Canadian Interventional Radiology Association Academic Article
-
Prevention and Management of Urgent/Emergent Limb Ischemia Academic Article
-
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone Academic Article
-
Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD) Academic Article
-
Real-Time Quantitative Measurements of Foot Perfusion in Patients With Critical Limb Ischemia Academic Article
-
Review of aspirin and clopidogrel resistance in peripheral arterial disease Academic Article
-
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial Academic Article
-
Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis Academic Article
-
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction Academic Article
-
Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease Academic Article
-
Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease Academic Article
-
Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization Academic Article
-
Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios Academic Article
-
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization Academic Article
-
Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial Academic Article
-
Rivaroxaban for the prevention of major adverse cardiovascular events in patients with coronary or peripheral artery disease Academic Article
-
Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment Academic Article
-
Rivaroxaban in Peripheral Artery Disease after Revascularization Academic Article
-
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits Academic Article
-
Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial Academic Article
-
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Academic Article
-
Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization Academic Article
-
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin Academic Article
-
Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD Academic Article
-
Social Deprivation and Peripheral Artery Disease Academic Article
-
Stroke Outcomes in the COMPASS Trial Academic Article
-
Subintimal recanalization of peripheral chronic occlusive arterial disease with modified transseptal needle Academic Article
-
Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease Academic Article
-
The Association of Cannabis Use Disorder with Acute Limb Ischemia and Critical Limb Ischemia Academic Article
-
The Time Has Come for Vascular Medicine in Canada Academic Article
-
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial Academic Article
-
The evolving treatment of peripheral arterial disease: preventing ischaemic events in the post-COMPASS era Academic Article
-
The predictive value of interarm systolic blood pressure differences in patients with vascular disease: Sub-analysis of the COMPASS trial Academic Article
-
The use of local anesthesia to perform lower limb revascularization in the fragile patient with critical limb ischemia. Academic Article
-
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study Academic Article
-
Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial Academic Article
-
Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial Academic Article
-
Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease Academic Article
-
Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease Academic Article
-
Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestations, and Outcomes Academic Article
-
Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both Academic Article
-
miR-29c-3p is an Effective Biomarker of Abdominal Aortic Aneurysm in Patients Undergoing Elective Surgery Academic Article